Toxicology Archives - Page 5 of 11 - REBEL EM

REBEL Core Cast – Basics of EM – Introduction

by Ellsworth Wright posted June 1, 2022 No Comments

REBEL Core Cast – Basics of Emergency Medicine Podcast Welcome to the EMRA Basics of Emergency Medicine Podcast. I am your host EJ Wright, and the following series is an all encompassing approach to the most common chief complaints in ...

Abdominal and GastroinstestinalAllergy and ImmunologyCardiovascularDermatologyEndocrine, Metabolic, Fluid, and ElectrolytesEnvironmentalHead, Eye, Ear, Nose, and ThroatHematology and OncologyInfectious DiseaseNeurologyObstetrics and GynecologyOrthopedicsRenal and GenitourinaryResuscitationThoracic and RespiratoryToxicologyTrauma

Massive Acetaminophen Overdose: Are We Giving Enough N-acetyl-cysteine?

by Christopher Hart, DO posted May 30, 2022 No Comments

Introduction: Acetaminophen, N-acetyl-p-aminophenol, or APAP, is one of the most commonly used medications worldwide. While it is generally safely used, overdose can result in the development of liver failure due to APAP’s hepatotoxic metabolites. Hepatic necrosis is preventable in overdose ...

Toxicology

Management of Digoxin Toxicity

by Santiago Lopez, MD, Katrina D'Amore, DO, John Kashani DO posted February 21, 2022 No Comments

A 78-year-old woman is brought in by EMS after her husband called 911 for increased confusion associated with intractable vomiting. On arrival to the emergency department (ED), the patient is altered with a heart rate of 48 and a blood ...

Toxicology

REBEL Cast Ep102: High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder

by Cara Borelli DO posted November 8, 2021 No Comments

Background information: Buprenorphine and buprenorphine-containing medications are being used in emergency departments for treatment of patients with opioid use disorder (1). Buprenorphine is a high-affinity partial agonist of the μ-opioid receptor. Buprenorphine has a higher affinity for the μ-opioid receptor ...

Toxicology

Droperidol: Making a Comeback!!!

by Salim Rezaie posted June 7, 2021 No Comments

Background: Droperidol came onto the market in 1967 and, over time, became a frequently employed treatment of headache, nausea, agitation, acute pain, chronic pain, pain in the context of opioid-tolerance and refractory abdominal pain. Unfortunately, in December 2011, the US ...

Toxicology